chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Fatigue, Headache, Myalgia
Clinical narrative: UTI/hurts to pee/went to bathroom 20 times; Dizziness; body shakes and shivers; Body ache/pain/pressure/soreness; Headache; body shakes and shivers; body is Tired; This spontaneous case was reported by a consumer and describes the occurrence of URINARY TRACT INFECTION (UTI/hurts to pee/went to bathroom 20 times), DIZZINESS (Dizziness), TREMOR (body shakes and shivers), MYALGIA (Body ache/pain/pressure/soreness) and HEADACHE (Headache) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 642B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported). Concomitant products included FOLIC ACID, METHOTREXATE and DICLOFENAC for an unknown indication, VITAMIN D NOS, ASCORBIC ACID (VITAMIN C ACID) and PREDNISONE.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced DIZZINESS (Dizziness), TREMOR (body shakes and shivers), MYALGIA (Body ache/pain/pressure/soreness), HEADACHE (Headache), CHILLS (body shakes and shivers) and FATIGUE (body is Tired). On 08-Apr-2021, the patient experienced URINARY TRACT INFECTION (UTI/hurts to pee/went to bathroom 20 times). At the time of the report, URINARY TRACT INFECTION (UTI/hurts to pee/went to bathroom 20 times), DIZZINESS (Dizziness), TREMOR (body shakes and shivers), MYALGIA (Body ache/pain/pressure/soreness), HEADACHE (Headache), CHILLS (body shakes and shivers) and FATIGUE (body is Tired) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor, Urinary tract infection
Clinical narrative: UTI/hurts to pee/went to bathroom 20 times; Dizziness; body shakes and shivers; Body ache/pain/pressure/soreness; Headache; body shakes and shivers; body is Tired; This spontaneous case was reported by a consumer and describes the occurrence of URINARY TRACT INFECTION (UTI/hurts to pee/went to bathroom 20 times), DIZZINESS (Dizziness), TREMOR (body shakes and shivers), MYALGIA (Body ache/pain/pressure/soreness) and HEADACHE (Headache) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 642B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported). Concomitant products included FOLIC ACID, METHOTREXATE and DICLOFENAC for an unknown indication, VITAMIN D NOS, ASCORBIC ACID (VITAMIN C ACID) and PREDNISONE.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced DIZZINESS (Dizziness), TREMOR (body shakes and shivers), MYALGIA (Body ache/pain/pressure/soreness), HEADACHE (Headache), CHILLS (body shakes and shivers) and FATIGUE (body is Tired). On 08-Apr-2021, the patient experienced URINARY TRACT INFECTION (UTI/hurts to pee/went to bathroom 20 times). At the time of the report, URINARY TRACT INFECTION (UTI/hurts to pee/went to bathroom 20 times), DIZZINESS (Dizziness), TREMOR (body shakes and shivers), MYALGIA (Body ache/pain/pressure/soreness), HEADACHE (Headache), CHILLS (body shakes and shivers) and FATIGUE (body is Tired) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Gait inability, Lethargy, Neuralgia, Somnolence
Clinical narrative: severe body shakes for over a minute that he couldn't control, felt like something electrical was happening; pain in nerves; could hardly walk; slept from 2 pm through to the next morning; no energy/ energy hasn't come back; lethargic; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (severe body shakes for over a minute that he couldn't control, felt like something electrical was happening), NEURALGIA (pain in nerves), GAIT INABILITY (could hardly walk), SOMNOLENCE (slept from 2 pm through to the next morning) and ASTHENIA (no energy/ energy hasn't come back) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 05-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, the patient experienced TREMOR (severe body shakes for over a minute that he couldn't control, felt like something electrical was happening), NEURALGIA (pain in nerves), GAIT INABILITY (could hardly walk), SOMNOLENCE (slept from 2 pm through to the next morning), ASTHENIA (no energy/ energy hasn't come back) and LETHARGY (lethargic). At the time of the report, TREMOR (severe body shakes for over a minute that he couldn't control, felt like something electrical was happening), NEURALGIA (pain in nerves), GAIT INABILITY (could hardly walk), SOMNOLENCE (slept from 2 pm through to the next morning), ASTHENIA (no energy/ energy hasn't come back) and LETHARGY (lethargic) outcome was unknown. Not Provided          Concomitant medications were not provided. The patient did not receive any treatment medications.   Most recent FOLLOW-UP information incorporated above includes: On 01-Jun-2021: Contact information updated for the reporter. On 21-Jun-2021: Follow up information received on 21-JUN-2021 contains no significant information On 01-Jul-2021: NNI
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: severe body shakes for over a minute that he couldn't control, felt like something electrical was happening; pain in nerves; could hardly walk; slept from 2 pm through to the next morning; no energy/ energy hasn't come back; lethargic; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (severe body shakes for over a minute that he couldn't control, felt like something electrical was happening), NEURALGIA (pain in nerves), GAIT INABILITY (could hardly walk), SOMNOLENCE (slept from 2 pm through to the next morning) and ASTHENIA (no energy/ energy hasn't come back) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 05-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, the patient experienced TREMOR (severe body shakes for over a minute that he couldn't control, felt like something electrical was happening), NEURALGIA (pain in nerves), GAIT INABILITY (could hardly walk), SOMNOLENCE (slept from 2 pm through to the next morning), ASTHENIA (no energy/ energy hasn't come back) and LETHARGY (lethargic). At the time of the report, TREMOR (severe body shakes for over a minute that he couldn't control, felt like something electrical was happening), NEURALGIA (pain in nerves), GAIT INABILITY (could hardly walk), SOMNOLENCE (slept from 2 pm through to the next morning), ASTHENIA (no energy/ energy hasn't come back) and LETHARGY (lethargic) outcome was unknown. Not Provided          Concomitant medications were not provided. The patient did not receive any treatment medications.   Most recent FOLLOW-UP information incorporated above includes: On 01-Jun-2021: Contact information updated for the reporter. On 21-Jun-2021: Follow up information received on 21-JUN-2021 contains no significant information On 01-Jul-2021: NNI
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache
Clinical narrative: Bad Chills; Fatigue; Headache; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Bad Chills), FATIGUE (Fatigue) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced CHILLS (Bad Chills), FATIGUE (Fatigue) and HEADACHE (Headache). At the time of the report, CHILLS (Bad Chills), FATIGUE (Fatigue) and HEADACHE (Headache) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.  No treatment medication were reported.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pyrexia
Clinical narrative: headaches and fever everyday; headaches and fever everyday; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headaches and fever everyday) and PYREXIA (headaches and fever everyday) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031l20a and 002a21a) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ATORVASTATIN CALCIUM (LIPITOR) for an unknown indication.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Feb-2021, the patient experienced HEADACHE (headaches and fever everyday) and PYREXIA (headaches and fever everyday). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency. At the time of the report, HEADACHE (headaches and fever everyday) and PYREXIA (headaches and fever everyday) had not resolved. Not Provided          Concomitant medication Lipitor. & Blood pressure medication.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Soft tissue mass, Vaccination site pain, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: soft at the injection site; itchy at the injection site; tender at the injection site; swollen at the injection site; a sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (a sore arm), SOFT TISSUE MASS (soft at the injection site), VACCINATION SITE PRURITUS (itchy at the injection site), VACCINATION SITE PAIN (tender at the injection site) and VACCINATION SITE SWELLING (swollen at the injection site) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included VORTIOXETINE HYDROBROMIDE (TRINTELLIX), FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR), MONTELUKAST SODIUM (SINGULAIR), VORTIOXETINE, GABAPENTIN, IPRATROPIUM BROMIDE, SALBUTAMOL SULFATE (IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE SOLUTION) and MONTELUKAST for an unknown indication.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced PAIN IN EXTREMITY (a sore arm). On 05-Apr-2021, the patient experienced VACCINATION SITE PRURITUS (itchy at the injection site), VACCINATION SITE PAIN (tender at the injection site) and VACCINATION SITE SWELLING (swollen at the injection site). On an unknown date, the patient experienced SOFT TISSUE MASS (soft at the injection site). On 26-Mar-2021, PAIN IN EXTREMITY (a sore arm) had not resolved. At the time of the report, SOFT TISSUE MASS (soft at the injection site), VACCINATION SITE PRURITUS (itchy at the injection site), VACCINATION SITE PAIN (tender at the injection site) and VACCINATION SITE SWELLING (swollen at the injection site) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications OTC Benadryl when needed  No treatment product information was provided
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: Tremors; This spontaneous case was reported by an other health care professional and describes the occurrence of TREMOR (Tremors) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced TREMOR (Tremors). At the time of the report, TREMOR (Tremors) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided. Treatment details were not provided.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Patient tries to drink water, but can't keep anything in her stomach after second dose; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (Patient tries to drink water, but can't keep anything in her stomach after second dose) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced VOMITING (Patient tries to drink water, but can't keep anything in her stomach after second dose). At the time of the report, VOMITING (Patient tries to drink water, but can't keep anything in her stomach after second dose) outcome was unknown. Not Provided          Concomitant medications were not provided. Treatment details were not provided.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Erythema, Fatigue, Hot flush, Mass excision
Clinical narrative: Pain in her arm; Very hot; Cold one day; Bump on her arm the size of a orange; Bump on the arm the size of a cantaloupe; Hardness in her arm; Muscle pain; Joint pain; Redness in her arm; Fatigue; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in her arm), HOT FLUSH (Very hot), NASOPHARYNGITIS (Cold one day), PERIPHERAL SWELLING (Bump on her arm the size of a orange) and MASS EXCISION (Bump on the arm the size of a cantaloupe) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced PAIN IN EXTREMITY (Pain in her arm), HOT FLUSH (Very hot), NASOPHARYNGITIS (Cold one day), PERIPHERAL SWELLING (Bump on her arm the size of a orange), MASS EXCISION (Bump on the arm the size of a cantaloupe), VACCINATION SITE INDURATION (Hardness in her arm), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain), ERYTHEMA (Redness in her arm), FATIGUE (Fatigue) and NAUSEA (Nausea). At the time of the report, PAIN IN EXTREMITY (Pain in her arm), HOT FLUSH (Very hot), NASOPHARYNGITIS (Cold one day), PERIPHERAL SWELLING (Bump on her arm the size of a orange), MASS EXCISION (Bump on the arm the size of a cantaloupe), VACCINATION SITE INDURATION (Hardness in her arm), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain), ERYTHEMA (Redness in her arm), FATIGUE (Fatigue) and NAUSEA (Nausea) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications Allergy medicine. Treatment medication antibiotics   This case was linked to US-MODERNATX, INC.-MOD-2021-071210, US-MODERNATX, INC.-MOD-2021-086105 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-071210:Daughter AE's US-MODERNATX, INC.-MOD-2021-086105:crosslinked
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nasopharyngitis, Nausea, Pain in extremity, Peripheral swelling
Clinical narrative: Pain in her arm; Very hot; Cold one day; Bump on her arm the size of a orange; Bump on the arm the size of a cantaloupe; Hardness in her arm; Muscle pain; Joint pain; Redness in her arm; Fatigue; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in her arm), HOT FLUSH (Very hot), NASOPHARYNGITIS (Cold one day), PERIPHERAL SWELLING (Bump on her arm the size of a orange) and MASS EXCISION (Bump on the arm the size of a cantaloupe) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced PAIN IN EXTREMITY (Pain in her arm), HOT FLUSH (Very hot), NASOPHARYNGITIS (Cold one day), PERIPHERAL SWELLING (Bump on her arm the size of a orange), MASS EXCISION (Bump on the arm the size of a cantaloupe), VACCINATION SITE INDURATION (Hardness in her arm), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain), ERYTHEMA (Redness in her arm), FATIGUE (Fatigue) and NAUSEA (Nausea). At the time of the report, PAIN IN EXTREMITY (Pain in her arm), HOT FLUSH (Very hot), NASOPHARYNGITIS (Cold one day), PERIPHERAL SWELLING (Bump on her arm the size of a orange), MASS EXCISION (Bump on the arm the size of a cantaloupe), VACCINATION SITE INDURATION (Hardness in her arm), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain), ERYTHEMA (Redness in her arm), FATIGUE (Fatigue) and NAUSEA (Nausea) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications Allergy medicine. Treatment medication antibiotics   This case was linked to US-MODERNATX, INC.-MOD-2021-071210, US-MODERNATX, INC.-MOD-2021-086105 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-071210:Daughter AE's US-MODERNATX, INC.-MOD-2021-086105:crosslinked
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site induration
Clinical narrative: Pain in her arm; Very hot; Cold one day; Bump on her arm the size of a orange; Bump on the arm the size of a cantaloupe; Hardness in her arm; Muscle pain; Joint pain; Redness in her arm; Fatigue; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in her arm), HOT FLUSH (Very hot), NASOPHARYNGITIS (Cold one day), PERIPHERAL SWELLING (Bump on her arm the size of a orange) and MASS EXCISION (Bump on the arm the size of a cantaloupe) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced PAIN IN EXTREMITY (Pain in her arm), HOT FLUSH (Very hot), NASOPHARYNGITIS (Cold one day), PERIPHERAL SWELLING (Bump on her arm the size of a orange), MASS EXCISION (Bump on the arm the size of a cantaloupe), VACCINATION SITE INDURATION (Hardness in her arm), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain), ERYTHEMA (Redness in her arm), FATIGUE (Fatigue) and NAUSEA (Nausea). At the time of the report, PAIN IN EXTREMITY (Pain in her arm), HOT FLUSH (Very hot), NASOPHARYNGITIS (Cold one day), PERIPHERAL SWELLING (Bump on her arm the size of a orange), MASS EXCISION (Bump on the arm the size of a cantaloupe), VACCINATION SITE INDURATION (Hardness in her arm), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain), ERYTHEMA (Redness in her arm), FATIGUE (Fatigue) and NAUSEA (Nausea) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications Allergy medicine. Treatment medication antibiotics   This case was linked to US-MODERNATX, INC.-MOD-2021-071210, US-MODERNATX, INC.-MOD-2021-086105 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-071210:Daughter AE's US-MODERNATX, INC.-MOD-2021-086105:crosslinked
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: administration of two doses; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (administration of two doses) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046A21A and 046A21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension and Kidney stones. Concomitant products included MELOXICAM (MOBIC), LISINOPRIL and ESCITALOPRAM OXALATE (LEXAPRO) for an unknown indication.   On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (administration of two doses). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (administration of two doses) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medications were not provided,
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Tested positive for covid; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Tested positive for covid) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Tested positive for covid). At the time of the report, SARS-COV-2 TEST POSITIVE (Tested positive for covid) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment details were not provided.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Nausea, Tachycardia
Clinical narrative: she felt dizzy; had a fast heart beat; nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (she felt dizzy), TACHYCARDIA (had a fast heart beat) and NAUSEA (nausea) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced DIZZINESS (she felt dizzy), TACHYCARDIA (had a fast heart beat) and NAUSEA (nausea). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Symptomatic treatment, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, DIZZINESS (she felt dizzy), TACHYCARDIA (had a fast heart beat) and NAUSEA (nausea) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication were not provided. Treatment information provided included  Benadryl and Tylenol.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Headache, Induration, Malaise
Clinical narrative: arm swollen; hardness; no hungry; felt not good; chills; little headache; nauseas; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (arm swollen), INDURATION (hardness), DECREASED APPETITE (no hungry), MALAISE (felt not good) and CHILLS (chills) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 13-Dec-2020. Concurrent medical conditions included Hypothyroidism. Concomitant products included LEVOTHYROXINE for Hypothyroidism.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, the patient experienced PERIPHERAL SWELLING (arm swollen), INDURATION (hardness), DECREASED APPETITE (no hungry), MALAISE (felt not good), CHILLS (chills), HEADACHE (little headache) and NAUSEA (nauseas). On 27-Mar-2021, HEADACHE (little headache) had resolved. At the time of the report, PERIPHERAL SWELLING (arm swollen), INDURATION (hardness), DECREASED APPETITE (no hungry), MALAISE (felt not good), CHILLS (chills) and NAUSEA (nauseas) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Dec-2020, SARS-CoV-2 test: positive Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Other Concomitant medication include medicine for blood clot, cholesterol statin, allergies, reflux and inhaler biold.  Treatment medication were not reported/unknown.   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Live follow up received on 10-May-2021: Updated Outcome of the Event chills, peripheral swelling, induration, decreased appetite, malaise, nausea from Unknown to Recovering. Patient declined for further followup.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Peripheral swelling, SARS-CoV-2 test
Clinical narrative: arm swollen; hardness; no hungry; felt not good; chills; little headache; nauseas; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (arm swollen), INDURATION (hardness), DECREASED APPETITE (no hungry), MALAISE (felt not good) and CHILLS (chills) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 13-Dec-2020. Concurrent medical conditions included Hypothyroidism. Concomitant products included LEVOTHYROXINE for Hypothyroidism.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, the patient experienced PERIPHERAL SWELLING (arm swollen), INDURATION (hardness), DECREASED APPETITE (no hungry), MALAISE (felt not good), CHILLS (chills), HEADACHE (little headache) and NAUSEA (nauseas). On 27-Mar-2021, HEADACHE (little headache) had resolved. At the time of the report, PERIPHERAL SWELLING (arm swollen), INDURATION (hardness), DECREASED APPETITE (no hungry), MALAISE (felt not good), CHILLS (chills) and NAUSEA (nauseas) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Dec-2020, SARS-CoV-2 test: positive Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Other Concomitant medication include medicine for blood clot, cholesterol statin, allergies, reflux and inhaler biold.  Treatment medication were not reported/unknown.   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Live follow up received on 10-May-2021: Updated Outcome of the Event chills, peripheral swelling, induration, decreased appetite, malaise, nausea from Unknown to Recovering. Patient declined for further followup.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Decreased appetite, Diarrhoea, Gastrointestinal pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of GASTROINTESTINAL PAIN, ORAL MUCOSAL BLISTERING, MUSCULOSKELETAL STIFFNESS, DECREASED APPETITE, and MUSCLE SPASMS in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 21-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced GASTROINTESTINAL PAIN, ORAL MUCOSAL BLISTERING, MUSCULOSKELETAL STIFFNESS, DECREASED APPETITE, MUSCLE SPASMS, ILLNESS, NECK PAIN, NECK PAIN, DIARRHOEA, ARTHRALGIA, PAIN, ARTHRALGIA, CHILLS, and VOMITING. At the time of the report, GASTROINTESTINAL PAIN, ORAL MUCOSAL BLISTERING, MUSCULOSKELETAL STIFFNESS, DECREASED APPETITE, MUSCLE SPASMS, ILLNESS, NECK PAIN, NECK PAIN, DIARRHOEA, ARTHRALGIA, PAIN, CHILLS, and VOMITING outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was unknown.       Concomitant medications were not provided. Treatment details were not provided.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Illness, Muscle spasms, Musculoskeletal stiffness, Neck pain, Oral mucosal blistering
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of GASTROINTESTINAL PAIN, ORAL MUCOSAL BLISTERING, MUSCULOSKELETAL STIFFNESS, DECREASED APPETITE, and MUSCLE SPASMS in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 21-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced GASTROINTESTINAL PAIN, ORAL MUCOSAL BLISTERING, MUSCULOSKELETAL STIFFNESS, DECREASED APPETITE, MUSCLE SPASMS, ILLNESS, NECK PAIN, NECK PAIN, DIARRHOEA, ARTHRALGIA, PAIN, ARTHRALGIA, CHILLS, and VOMITING. At the time of the report, GASTROINTESTINAL PAIN, ORAL MUCOSAL BLISTERING, MUSCULOSKELETAL STIFFNESS, DECREASED APPETITE, MUSCLE SPASMS, ILLNESS, NECK PAIN, NECK PAIN, DIARRHOEA, ARTHRALGIA, PAIN, CHILLS, and VOMITING outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was unknown.       Concomitant medications were not provided. Treatment details were not provided.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Vomiting
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of GASTROINTESTINAL PAIN, ORAL MUCOSAL BLISTERING, MUSCULOSKELETAL STIFFNESS, DECREASED APPETITE, and MUSCLE SPASMS in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 21-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced GASTROINTESTINAL PAIN, ORAL MUCOSAL BLISTERING, MUSCULOSKELETAL STIFFNESS, DECREASED APPETITE, MUSCLE SPASMS, ILLNESS, NECK PAIN, NECK PAIN, DIARRHOEA, ARTHRALGIA, PAIN, ARTHRALGIA, CHILLS, and VOMITING. At the time of the report, GASTROINTESTINAL PAIN, ORAL MUCOSAL BLISTERING, MUSCULOSKELETAL STIFFNESS, DECREASED APPETITE, MUSCLE SPASMS, ILLNESS, NECK PAIN, NECK PAIN, DIARRHOEA, ARTHRALGIA, PAIN, CHILLS, and VOMITING outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was unknown.       Concomitant medications were not provided. Treatment details were not provided.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue
Clinical narrative: little bit of shortness of breath, she was out of breath; got tired very easily; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (little bit of shortness of breath, she was out of breath) and FATIGUE (got tired very easily) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 023M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  The patient's past medical history included Scoliosis and Sciatica. Concomitant products included HYDROCODONE BITARTRATE, PARACETAMOL (NORCO) for an unknown indication.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In February 2021, the patient experienced DYSPNOEA (little bit of shortness of breath, she was out of breath) and FATIGUE (got tired very easily). At the time of the report, DYSPNOEA (little bit of shortness of breath, she was out of breath) and FATIGUE (got tired very easily) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Patient had low hemoglobin since it resolved on its own after a transfusion after the second dose of the vaccine.   This case was linked to MOD-2021-071259 (Patient Link).
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Chills, Fatigue, Headache
Clinical narrative: Back pain; Chills; Headache; Myalgia; Fatigue; shoulder pain; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Back pain), CHILLS (Chills), HEADACHE (Headache), MYALGIA (Myalgia) and FATIGUE (Fatigue) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced BACK PAIN (Back pain), CHILLS (Chills), HEADACHE (Headache), MYALGIA (Myalgia), FATIGUE (Fatigue) and ARTHRALGIA (shoulder pain). On 08-Apr-2021, BACK PAIN (Back pain), CHILLS (Chills), HEADACHE (Headache), MYALGIA (Myalgia) and FATIGUE (Fatigue) had resolved and ARTHRALGIA (shoulder pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant information was provided. No treatment information was provided.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Back pain; Chills; Headache; Myalgia; Fatigue; shoulder pain; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Back pain), CHILLS (Chills), HEADACHE (Headache), MYALGIA (Myalgia) and FATIGUE (Fatigue) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced BACK PAIN (Back pain), CHILLS (Chills), HEADACHE (Headache), MYALGIA (Myalgia), FATIGUE (Fatigue) and ARTHRALGIA (shoulder pain). On 08-Apr-2021, BACK PAIN (Back pain), CHILLS (Chills), HEADACHE (Headache), MYALGIA (Myalgia) and FATIGUE (Fatigue) had resolved and ARTHRALGIA (shoulder pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant information was provided. No treatment information was provided.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Heart rate increased, Influenza like illness, Myalgia, Pyrexia
Clinical narrative: Difficulty in breathing; Rapid heart beats; She feels achy and had flu like symptoms; Muscle ache; Fever; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Difficulty in breathing), HEART RATE INCREASED (Rapid heart beats), INFLUENZA LIKE ILLNESS (She feels achy and had flu like symptoms), MYALGIA (Muscle ache) and PYREXIA (Fever) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LEVOTHYROXINE SODIUM (L-THYROXIN 1A PHARMA) for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, the patient experienced DYSPNOEA (Difficulty in breathing), HEART RATE INCREASED (Rapid heart beats), INFLUENZA LIKE ILLNESS (She feels achy and had flu like symptoms), MYALGIA (Muscle ache) and PYREXIA (Fever). The patient was treated with LORATADINE (CLARITIN [LORATADINE]) for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, DYSPNOEA (Difficulty in breathing), HEART RATE INCREASED (Rapid heart beats), INFLUENZA LIKE ILLNESS (She feels achy and had flu like symptoms), MYALGIA (Muscle ache) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication L-thyroxin
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Exhaustion; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Exhaustion) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced FATIGUE (Exhaustion). At the time of the report, FATIGUE (Exhaustion) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant information was provided. No treatment information was provided.   This case was linked to MOD21-072110 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 08-Apr-2021: No specific follow-up information recorded.; Sender's Comments:  MOD21-072110:
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose increased, Body temperature, Dizziness, Hyperhidrosis, Myalgia
Clinical narrative: her sugar is raised; sweats; body hurt/ pain (in back chest, and arm); fever 101.3; dizzy; nausea; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE INCREASED (her sugar is raised), HYPERHIDROSIS (sweats), DIZZINESS (dizzy), NAUSEA (nausea) and MYALGIA (body hurt/ pain (in back chest, and arm)) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, the patient experienced DIZZINESS (dizzy), NAUSEA (nausea) and PYREXIA (fever 101.3). On an unknown date, the patient experienced BLOOD GLUCOSE INCREASED (her sugar is raised), HYPERHIDROSIS (sweats) and MYALGIA (body hurt/ pain (in back chest, and arm)). At the time of the report, BLOOD GLUCOSE INCREASED (her sugar is raised) was resolving and HYPERHIDROSIS (sweats), DIZZINESS (dizzy), NAUSEA (nausea), MYALGIA (body hurt/ pain (in back chest, and arm)) and PYREXIA (fever 101.3) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Apr-2021, Body temperature: 101.3 (High) 101.3. On 08-Apr-2021, Body temperature: 99.3 (Low) 99.3.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided. Treatment details were not provided.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia
Clinical narrative: her sugar is raised; sweats; body hurt/ pain (in back chest, and arm); fever 101.3; dizzy; nausea; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE INCREASED (her sugar is raised), HYPERHIDROSIS (sweats), DIZZINESS (dizzy), NAUSEA (nausea) and MYALGIA (body hurt/ pain (in back chest, and arm)) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, the patient experienced DIZZINESS (dizzy), NAUSEA (nausea) and PYREXIA (fever 101.3). On an unknown date, the patient experienced BLOOD GLUCOSE INCREASED (her sugar is raised), HYPERHIDROSIS (sweats) and MYALGIA (body hurt/ pain (in back chest, and arm)). At the time of the report, BLOOD GLUCOSE INCREASED (her sugar is raised) was resolving and HYPERHIDROSIS (sweats), DIZZINESS (dizzy), NAUSEA (nausea), MYALGIA (body hurt/ pain (in back chest, and arm)) and PYREXIA (fever 101.3) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Apr-2021, Body temperature: 101.3 (High) 101.3. On 08-Apr-2021, Body temperature: 99.3 (Low) 99.3.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided. Treatment details were not provided.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: covid-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (covid-19) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COVID-19 (covid-19). At the time of the report, COVID-19 (covid-19) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided. Treatment details were not provided.    This case was linked to US-MODERNATX, INC.-MOD-2021-071427 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-071427:
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: is red and itchy; swelling around where shot; is red and itchy; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 07-Apr-2021 and was forwarded to Moderna on 07-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (is red and itchy), VACCINATION SITE SWELLING (swelling around where shot) and VACCINATION SITE ERYTHEMA (is red and itchy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No Medical history reported).   On 02-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced VACCINATION SITE PRURITUS (is red and itchy), VACCINATION SITE SWELLING (swelling around where shot) and VACCINATION SITE ERYTHEMA (is red and itchy). At the time of the report, VACCINATION SITE PRURITUS (is red and itchy), VACCINATION SITE SWELLING (swelling around where shot) and VACCINATION SITE ERYTHEMA (is red and itchy) outcome was unknown.            Treatment medication included topical Benadryl cream.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: her left leg has a hand sized area numb; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (her left leg has a hand sized area numb) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced HYPOAESTHESIA (her left leg has a hand sized area numb). At the time of the report, HYPOAESTHESIA (her left leg has a hand sized area numb) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment details were not provided.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dizziness, Fatigue, Headache, Nausea
Clinical narrative: feeling light headed; headaches; fatigue; nausea; chills; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (feeling light headed), HEADACHE (headaches), FATIGUE (fatigue), NAUSEA (nausea) and CHILLS (chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced DIZZINESS (feeling light headed), HEADACHE (headaches), FATIGUE (fatigue), NAUSEA (nausea) and CHILLS (chills). At the time of the report, DIZZINESS (feeling light headed), HEADACHE (headaches), FATIGUE (fatigue), NAUSEA (nausea) and CHILLS (chills) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment details were not provided.